These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1894756)

  • 1. The effect of pirmenol administration on the anti-coagulant activity of warfarin.
    Stringer KA; Switzer DF; Abadier R; Lebsack ME; Sedman A; Chrymko M
    J Clin Pharmacol; 1991 Jul; 31(7):607-10. PubMed ID: 1894756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics and pharmacokinetics of oral pirmenol.
    Ellenbogen KA; Roark SF; Sintetos AL; Smith MS; McCarthy EA; Smith WM; Kates RE; Pritchett EL
    Clin Pharmacol Ther; 1987 Oct; 42(4):405-10. PubMed ID: 3665339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and pharmacokinetics of oral pirmenol, a new antiarrhythmic drug.
    Garg DC; Jallad NS; Singh S; Ng KF; Weidler DJ
    J Clin Pharmacol; 1988 Sep; 28(9):812-7. PubMed ID: 2466056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced pirmenol elimination by rifampin.
    Stringer KA; Cetnarowski AB; Goldfarb A; Lebsack ME; Chang T; Sedman AJ
    J Clin Pharmacol; 1988 Dec; 28(12):1094-7. PubMed ID: 3243925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrocardiographic and electrophysiologic effects of pirmenol in ventricular tachycardia.
    Estes NA; Gold R; Cameron J; Haffajee C; Marshall M; Mack K; Salem DN
    Am J Cardiol; 1987 Jun; 59(16):20H-26H. PubMed ID: 3591711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pirmenol enantiomers and pharmacodynamics of pirmenol racemate in patients with premature ventricular contractions.
    Janiczek N; Smith DE; Chang T; Sedman AJ; Stringer KA
    J Clin Pharmacol; 1997 Jun; 37(6):502-13. PubMed ID: 9208357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole potentiates warfarin-induced prothrombin time prolongation.
    Purkins L; Wood N; Kleinermans D; Nichols D
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):24-9. PubMed ID: 14616410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cimetidine administration on the pharmacokinetics of pirmenol.
    Stringer KA; Lebsack ME; Cetnarowski-Cropp AB; Goldfarb AL; Radulovic LL; Bockbrader HN; Chang T; Sedman AJ
    J Clin Pharmacol; 1992 Jan; 32(1):91-4. PubMed ID: 1740542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical pharmacokinetics of pirmenol.
    Chang T
    Am J Cardiol; 1987 Jun; 59(16):15H-19H. PubMed ID: 2438922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pirmenol on premature atrial complexes.
    Toivonen LK
    Ann Clin Res; 1986; 18(2):106-8. PubMed ID: 3521442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical toxicology of pirmenol hydrochloride.
    Martin RA; de la Iglesia FA
    Am J Cardiol; 1987 Jun; 59(16):10H-14H. PubMed ID: 3591709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology and pharmacokinetics of pirmenol.
    Reiter MJ
    Angiology; 1988 Mar; 39(3 Pt 2):293-8. PubMed ID: 3281518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of tacrine administration on the anticoagulant activity of warfarin.
    Reece PA; Garnett WR; Rock WL; Taylor JR; Underwood B; Sedman AJ; Rajagopalan R
    J Clin Pharmacol; 1995 May; 35(5):526-8. PubMed ID: 7657855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute haemodynamic effects of the antiarrhythmic agent pirmenol in cardiac patients: a comparison with lidocaine.
    Nieminen MS; Toivonen LK; Manninen V; Frick MH
    Eur Heart J; 1986 Feb; 7(2):150-7. PubMed ID: 3516703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide.
    Gold RL; Frumin H; Haffajee CI; Kerin NZ; Jarandilla R
    Pacing Clin Electrophysiol; 1988 Mar; 11(3):308-14. PubMed ID: 2452418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
    Sato K; Taniuchi Y; Kawasaki T; Hirayama F; Koshio H; Matsumoto Y; Iizumi Y
    Jpn J Pharmacol; 1998 Oct; 78(2):191-7. PubMed ID: 9829622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of pirmenol in young and elderly subjects.
    Ferry DG; Campbell AJ; Bland R; Beasley M; Gazeley L; Edwards IR
    Eur J Clin Pharmacol; 1992; 43(4):437-9. PubMed ID: 1451728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study.
    Anderson JL; Lutz JR; Nappi JM
    Am J Cardiol; 1984 Feb; 53(4):522-7. PubMed ID: 6198894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacology of pirmenol.
    Kaplan HR; Mertz TE; Steffe TJ
    Am J Cardiol; 1987 Jun; 59(16):2H-9H. PubMed ID: 3591710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.